Cancer News and Research

Latest Cancer News and Research

Dysregulation of innate lymphoid cells drives colon cancer progression and immunotherapy resistance

An immune cell subset called innate lymphoid cells (ILC3s) protects against colorectal cancer, in part by helping to maintain a healthy dialogue between the immune system and gut microbes, according to a new study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian. The finding opens the door to new strategies for treating this type of cancer.

17 Aug 2021

Vitamin D intake associated with lower risk of developing young-onset colorectal cancer

Consuming higher amounts of Vitamin D – mainly from dietary sources – may help protect against developing young-onset colorectal cancer or precancerous colon polyps, according to the first study to show such an association.

17 Aug 2021

New clinical trial investigates aspirin as part of new treatment for triple negative breast cancer

An innovative new study is trialing whether giving aspirin, commonly used as pain relief, alongside immunotherapy drug avelumab could improve its effectiveness for people affected by breast cancer.

17 Aug 2021

Research reveals link between widespread pain and heightened risk of dementia, stroke

Widespread pain is linked to a heightened risk of all types of dementia, including Alzheimer's disease, and stroke finds research.

17 Aug 2021

MGH researchers discover how triple-negative breast cancer can evade powerful drugs

Massachusetts General Hospital researchers have identified for the first time how a highly aggressive form of breast cancer can evade one of the most powerful and effective drugs used to treat it, reporting their findings in Cancer Discovery, a journal of the American Association for Cancer Research.

17 Aug 2021

Researchers confirm the speed, simplicity and accuracy of new COVID-19 testing method

Researchers from the University of Birmingham, U.K., have confirmed the speed, accuracy, and simplicity of a novel, a highly sensitive testing method for COVID-19 that can be deployed at entertainment venues, airport arrival terminals, and in remote settings where clinical testing laboratories are not available.

17 Aug 2021

AIHW report: Modifiable risk factors cause one-third of disease burden

The overall health of Australians continues to improve, however, a new report from the Australian Institute of Health and Welfare for 2018 show that further gains could be achieved by reducing leading risk factors such as tobacco use, overweight, and high blood pressure.

17 Aug 2021

New evidence-based approach to defining high-quality carbohydrate foods

For decades, people have often associated higher intakes of carbohydrate-containing foods with less healthy lifestyles.

16 Aug 2021

Hedgehog-signaling inhibitor may shift tumor-associated macrophages back to cancer fighters

A form of cell communication called hedgehog signaling is vital for embryonic development in mammals.

16 Aug 2021

Experimental drug and immunotherapy combination shows promise in bladder cancer study

A new study in mice found that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission.

16 Aug 2021

Treatment with stem cell grafts promotes tendon healing in sheep

Tendon injuries in sheep that were treated with stem cell grafts achieved, in just two months, a diameter and hardness similar to the original healthy tendon, according to the results of a study released in STEM CELLS Translational Medicine.

16 Aug 2021

Bioengineers develop implantable piezoelectric therapeutic devices

Bioengineers have developed biocompatible generators that create electrical pulses when compressed by body motions.

16 Aug 2021

Combining inhibitor drug with immunotherapy agent improves response in cancer patients

Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.

16 Aug 2021

Study identifies mechanism of resistance and presents a much-needed target for advanced leukemias

Too many "exhausted" T cells left in the wake of aggressive chemotherapy regimens for patients with advanced chronic lymphocytic leukemia (CLL) make it more challenging for chimeric antigen receptor (CAR) T cell therapy to do its job.

16 Aug 2021

NIH scientists develop new sample preparation method to detect SARS-CoV-2

Scientists at the National Institutes of Health (NIH) have developed a new sample preparation method to detect SARS-Cov-2, the virus that causes COVID-19.

16 Aug 2021

Penn researchers reveal complex details of T-cell responses to mRNA COVID-19 vaccines

Messenger-RNA (mRNA) vaccines against the coronavirus that causes COVID-19 provoke a swift and strong response by the immune system's T cells - the heavy armor of the immune system - according to a study from researchers in the Perelman School of Medicine at the University of Pennsylvania.

16 Aug 2021

Excluding race factor from kidney function estimates may affect clinical outcomes for Black cancer patients

Removing race as a factor in a kidney function-estimating equation used to guide cancer treatment dosing and eligibility may decrease the proportion of Black patients recommended to receive full doses of anticancer drugs.

16 Aug 2021

World-first trial of third dose COVID-19 booster vaccine shows improved protection in transplant patients

Scientists with the Ajmera Transplant Centre at UHN have conducted a first-in-the-world randomized placebo-controlled trial of third dose COVID-19 booster vaccine for transplant patients that shows substantially improved protection.

14 Aug 2021

Study helps to clarify the post-clinical trial needs of cancer patients

Cancer clinical trials (CCTs) provide patients an opportunity to receive experimental drugs, tests, and/or procedures that can lead to remissions. For some, a CCT may seem like their only option. Yet little is known about the experiences of patient participants who withdraw from CCTs.

14 Aug 2021

Removal of race from kidney function estimates may negatively impact care for Black cancer patients

An accurate assessment of a patient's kidney function is critical for determining eligibility for anticancer treatments.

14 Aug 2021

Cancer News and Research

Latest Cancer News and Research

Dysregulation of innate lymphoid cells drives colon cancer progression and immunotherapy resistance

Vitamin D intake associated with lower risk of developing young-onset colorectal cancer

New clinical trial investigates aspirin as part of new treatment for triple negative breast cancer

Research reveals link between widespread pain and heightened risk of dementia, stroke

MGH researchers discover how triple-negative breast cancer can evade powerful drugs

Researchers confirm the speed, simplicity and accuracy of new COVID-19 testing method

AIHW report: Modifiable risk factors cause one-third of disease burden

New evidence-based approach to defining high-quality carbohydrate foods

Hedgehog-signaling inhibitor may shift tumor-associated macrophages back to cancer fighters

Experimental drug and immunotherapy combination shows promise in bladder cancer study

Treatment with stem cell grafts promotes tendon healing in sheep

Bioengineers develop implantable piezoelectric therapeutic devices

Combining inhibitor drug with immunotherapy agent improves response in cancer patients

Study identifies mechanism of resistance and presents a much-needed target for advanced leukemias

NIH scientists develop new sample preparation method to detect SARS-CoV-2

Penn researchers reveal complex details of T-cell responses to mRNA COVID-19 vaccines

Excluding race factor from kidney function estimates may affect clinical outcomes for Black cancer patients

World-first trial of third dose COVID-19 booster vaccine shows improved protection in transplant patients

Study helps to clarify the post-clinical trial needs of cancer patients

Removal of race from kidney function estimates may negatively impact care for Black cancer patients

Understanding the DNA Damage Response in Innate Immunity eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in